Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer

ABSTRACT: A randomized, controlled phase II clinical trial of Fruquintinib combined with Raltitrexed versus Fruquintinib monotherapy in patients with advanced colorectal cancer who had failed second-line or above standard chemotherapy

DISEASE(S): Advanced Colorectal Carcinoma,Colorectal Neoplasms

PROVIDER: 2354180 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR